PT  - JOURNAL ARTICLE
AU  - Tan, Jianbin
AU  - Ge, Yang
AU  - Martinez, Leonardo
AU  - Sun, Jimin
AU  - Li, Changwei
AU  - Westbrook, Adrianna
AU  - Chen, Enfu
AU  - Pan, Jinren
AU  - Li, Yang
AU  - Ling, Feng
AU  - Chen, Zhiping
AU  - Huang, Hui
AU  - Shen, Ye
TI  - Transmission roles of symptomatic and asymptomatic COVID-19 cases: a modeling study
AID  - 10.1101/2021.05.11.21257060
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.05.11.21257060
4099  - http://medrxiv.org/content/early/2021/09/21/2021.05.11.21257060.short
4100  - http://medrxiv.org/content/early/2021/09/21/2021.05.11.21257060.full
AB  - Question What is the transmissibility of COVID-19 asymptomatic and symptomatic cases, respectively? To date, they have not been well quantified in existing literature.Findings The transmissibility of asymptomatic and symptomatic COVID-19 increases with patient age. The asymptomatic cases had a 66.72% lower transmissibility rate than symptomatic cases.Meaning The transmissibility of asymptomatic COVID-19 cases is not low. Asymptomatic cases are harder to detect compared to symptomatic cases. Consequently, the burden of asymptomatic transmission could potentially dominate the spreading in certain scenarios.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study is funded by Zhejiang Basic Public Welfare Research Project grant LGF21H260003.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The research protocol was approved by the institutional review board at the Zhejiang Provincial Center for Disease Control and Prevention.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets are available from the corresponding author on reasonable request.